183 related articles for article (PubMed ID: 9439927)
1. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
3. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
[TBL] [Abstract][Full Text] [Related]
4. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
6. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
[TBL] [Abstract][Full Text] [Related]
9. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
Li X; Huang G; Yan X; Yang L; Zhou ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
[TBL] [Abstract][Full Text] [Related]
10. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
11. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
Huang YY; Huang P; Lou HL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
[TBL] [Abstract][Full Text] [Related]
12. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.
Zhou Z; Ouyang L; Peng J; Yang W; Wang J; Zhu X; Wu H; Dyrberg T
Chin Med J (Engl); 1999 Jun; 112(6):554-7. PubMed ID: 11601338
[TBL] [Abstract][Full Text] [Related]
14. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
16. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
[TBL] [Abstract][Full Text] [Related]
18. [Study on the postive frequency and distribution of glutamic acid decarboxylase antibody in phenotypic type 2 diabetec patients].
Li X; Zhou ZG; Haung G; Peng J; Yan X; Yang L; Wang JP; Deng ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):800-3. PubMed ID: 16536308
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes.
Unnikrishnan AG; Singh SK; Sanjeevi CB
Ann N Y Acad Sci; 2004 Dec; 1037():118-21. PubMed ID: 15699503
[TBL] [Abstract][Full Text] [Related]
20. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
